This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1978 Dec;5(4):199-207.

doi: 10.1016/s0305-7372(78)80014-0.

Maytansine

B F Issell, S T Crooke

PMID: 367597
DOI: 10.1016/s0305-7372(78)80014-0

Review

Maytansine

B F Issell et al. Cancer Treat Rev. 1978 Dec.

. 1978 Dec;5(4):199-207.

doi: 10.1016/s0305-7372(78)80014-0.

Authors

B F Issell, S T Crooke

PMID: 367597
DOI: 10.1016/s0305-7372(78)80014-0

No abstract available

PubMed Disclaimer

Similar articles

Stathmokinetic and therapeutic effects of maytansine in mice bearing P388 and L1210 leukemias.
Johnson RK, Inouye T, Wolpert-DeFilippes MK. Johnson RK, et al. Biochem Pharmacol. 1978;27(15):1973-5. doi: 10.1016/0006-2952(78)90014-x. Biochem Pharmacol. 1978. PMID: 708479 No abstract available.
Experimental studies with maytansine--a new antitumor agent.
Sieber SM, Wolpert MK, Adamson RH, Cysyk RL, Bono VH, Johns DG. Sieber SM, et al. Bibl Haematol. 1975 Oct;(43):495-500. doi: 10.1159/000399202. Bibl Haematol. 1975. PMID: 1067087 No abstract available.
Phase I study of weekly maytansine given by iv bolus or 24-hour infusion.
Chahinian AP, Nogeire C, Ohnuma T, Greenberg ML, Sivak M, Jaffrey IS, Holland JF. Chahinian AP, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1953-60. Cancer Treat Rep. 1979. PMID: 526928 No abstract available.
Pharmacology of antitumor agents from higher plants.
Sieber SM, Mead JA, Adamson RH. Sieber SM, et al. Cancer Treat Rep. 1976 Aug;60(8):1127-39. Cancer Treat Rep. 1976. PMID: 136296 Review.
Amsacrine: a review.
Cassileth PA, Gale RP. Cassileth PA, et al. Leuk Res. 1986;10(11):1257-65. doi: 10.1016/0145-2126(86)90331-0. Leuk Res. 1986. PMID: 3540460 Review.

See all similar articles

Cited by

ADME of antibody-maytansinoid conjugates.
Erickson HK, Lambert JM. Erickson HK, et al. AAPS J. 2012 Dec;14(4):799-805. doi: 10.1208/s12248-012-9386-x. Epub 2012 Aug 9. AAPS J. 2012. PMID: 22875610 Free PMC article. Review.
Beyond the Paclitaxel and Vinca Alkaloids: Next Generation of Plant-Derived Microtubule-Targeting Agents with Potential Anticancer Activity.
Zhang D, Kanakkanthara A. Zhang D, et al. Cancers (Basel). 2020 Jun 29;12(7):1721. doi: 10.3390/cancers12071721. Cancers (Basel). 2020. PMID: 32610496 Free PMC article. Review.
Advances and Prospects of Prolamine Corn Protein Zein as Promising Multifunctional Drug Delivery System for Cancer Treatment.
Luo X, Wu S, Xiao M, Gu H, Zhang H, Chen J, Liu Y, Zhang C, Zhang J. Luo X, et al. Int J Nanomedicine. 2023 May 15;18:2589-2621. doi: 10.2147/IJN.S402891. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37213352 Free PMC article. Review.
Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer.
Okines AF, Cunningham D. Okines AF, et al. Therap Adv Gastroenterol. 2012 Sep;5(5):301-18. doi: 10.1177/1756283X12450246. Therap Adv Gastroenterol. 2012. PMID: 22973416 Free PMC article.
Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer.
Yu X, Wu H, Hu H, Dong Z, Dang Y, Qi Q, Wang Y, Du S, Lu Y. Yu X, et al. Drug Deliv. 2020 Dec;27(1):100-109. doi: 10.1080/10717544.2019.1704942. Drug Deliv. 2020. PMID: 31870183 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database